Each year, hundreds of millions of people undergo elective surgery or surgery following trauma and are left with scarring. In some cases, such as following appendix removal, the scar may be small enough to go unnoticed. But as the number of traumatic incidents—severe burns, car injuries—rises, so does the incidence of major scarring, which can be both physically and psychologically debilitating. Over 90% of the cases of severe burns occur among a particularly sensitive group—children aged 16 years or less. Although existing wound healing products, such as tissue engineered skin replacements, help restore skin following such extensive injury, there are currently no effective pharmacological treatments to prevent the scarring such procedures can lead to. And rising demand for cosmetic surgery—where an ugly scar could potentially undo the perceived value—suggests that the market for an anti-scarring product extends well beyond accident and burn victims.
Renovo, a spin-off from the University of Manchester, and the first from the Manchester Biotechnology Incubator, was set up two...






